{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:45:30Z","timestamp":1765039530564},"reference-count":25,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Clinical Toxicology"],"published-print":{"date-parts":[[2021,4,3]]},"DOI":"10.1080\/15563650.2020.1814318","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T15:25:28Z","timestamp":1599492328000},"page":"303-312","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Respiratory depression following medications for opioid use disorder (MOUD)-approved buprenorphine product oral exposures; National Poison Database System 2003\u20132019"],"prefix":"10.1080","volume":"59","author":[{"given":"Michael A.","family":"Darracq","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, Division of Medical Toxicology, Fresno Medical Education Program, University of California, San Francisco (UCSF), Fresno, CA, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen L.","family":"Thornton","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Kansas Poison Control System, University of Kansas Health System, Kansas City, KS, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,9,7]]},"reference":[{"key":"CIT0001","unstructured":"HHS: what is the U.S. opioid epidemic. Washington (DC): US Department of Health and Human Services; [cited 2019 Sep 4]; 2019. Available from: https:\/\/www.hhs.gov\/opioids\/about-the-epidemic\/index.html"},{"key":"CIT0002","unstructured":"HHS: secretary price announces HHS strategy for fighting opioid crisis. Washington (DC): US Department of Health and Human Services; [cited 2017 Apr 19]; 2017. Available from: https:\/\/www.hhs.gov\/about\/leadership\/secretary\/speeches\/2017-speeches\/secretary-price-announces-hhs-strategy-for-fighting-opioid-crisis\/index.html"},{"key":"CIT0003","unstructured":"SAMHSA: medication assisted treatment (MAT). Washington (DC): Substance Abuse and Mental Health Services Administration; [cited 2020 Jul 9]; 2020. Available from: https:\/\/www.samhsa.gov\/medication-assisted-treatment"},{"key":"CIT0004","unstructured":"SAMHSA: buprenorphine. Washington (DC). Substance Abuse and Mental Health Services Administration; [cited 2020 May 4]; 2020. Available from: https:\/\/www.samhsa.gov\/medication-assisted-treatment\/treatment\/buprenorphine"},{"key":"CIT0005","unstructured":"SAMHSA: statues, regulations, and guidelines. Washington (DC): Substance Abuse and Mental Health Services Administration; [cited 2020 Jul 22]; 2020. Available from: https:\/\/www.samhsa.gov\/medication-assisted-treatment\/statutes-regulations-guidelines"},{"key":"CIT0006","unstructured":"American Society of Health-System Pharmacists: buprenorphine hydrochloride. Bethesda (MD). AHFS DI Essentials\u2122; [cited 2020 Jul 24]; 2020. Available from: https:\/\/www.drugs.com\/monograph\/buprenorphine-buprenorphine-hydrochloride.html"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.23-32-10331.2003"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(02)00486-4"},{"key":"CIT0009","unstructured":"AAPCC: National Poison Data System (NPDS). Arlington (VA). American Association of Poison Control Centers; 2017. Available from: https:\/\/aapcc.org\/data-system"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2019.1677022"},{"key":"CIT0011","unstructured":"US Department of Justice, Drug Enforcement Administration. ARCOS retail drug summary reports. Springfield (MA). Drug Enforcement Administration. Available from: https:\/\/www.deadiversion.usdoj.gov\/arcos\/retail_drug_summary"},{"key":"CIT0012","unstructured":"SAMHSA: trends in the use of methadone, buprenorphine, and extended release naltrexone at substance abuse treatment facilities: 2003\u20132015 (update). Washington (DC). Substance Abuse and Mental Health Services Administration; [cited 2017 Aug 22]; 2017. Available from: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/report_3192\/ShortReport-3192.html"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201700315"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2014.02.003"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2012.05.025"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.5414\/CP203118"},{"issue":"2","key":"CIT0017","first-page":"688","volume":"297","author":"Huang P","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.115972"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e318265680a"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.3.447-b"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/22.6.430"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1520\/JFS14667J"},{"key":"CIT0023","unstructured":"MEDSAFE. Drug metabolism\u2014the importance of cytochrome P450 3A4. New Zealand Medicines and Medical Devices Safety Authority; [cited 2014 Mar 6]; 2014. Available from: https:\/\/www.medsafe.govt.nz\/profs\/puarticles\/march2014drugmetabolismcytochromep4503a4.htm"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1111\/add.13925"},{"key":"CIT0025","volume-title":"Drug overdose deaths in the United States, 1999\u20132018. NCHS data brief no. 356","author":"Hedegaard H","year":"2020"}],"container-title":["Clinical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15563650.2020.1814318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T16:32:08Z","timestamp":1620405128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15563650.2020.1814318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,7]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4,3]]}},"alternative-id":["10.1080\/15563650.2020.1814318"],"URL":"https:\/\/doi.org\/10.1080\/15563650.2020.1814318","relation":{},"ISSN":["1556-3650","1556-9519"],"issn-type":[{"value":"1556-3650","type":"print"},{"value":"1556-9519","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ictx20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ictx20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-05-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}